NRx Pharmaceuticals, Inc.

NASDAQ:NRXP

1.265 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Omzet 000.0080000000000000000000000000
Kosten van de omzet 0.0010.0010.0010.0020.0010.0010.0010.0010.0010.00100.0010.00100.90700000001.0070.220.2720.19200
Brutowinst -0.001-0.0010.007-0.002-0.001-0.001-0.001-0.001-0.001-0.001-0-0.001-0.0010-0.9070000000-1.007-0.22-0.272-0.19200
Brutowinstmarge 000.8750000000000000000000000000
Onderzoek- en ontwikkelingskosten 2.8041.7482.5343.3143.8733.654.4564.1292.9585.4836.4136.2764.6592.9094.2994.3321.390.0010.001000000000
Algemene en administratieve kosten 4.2464.251.8722.4944.0655.7855.4325.0126.64210.22246.56213.82312.4582.1016.5413.7540.5260.0010.001000.1630.3220.220.2720.19200
Verkoop- en marketingkosten -0.001-0.001-0.001000000013,809.42200000000.028000000000
Verkoop-, algemene en administratieve kosten 4.2454.2491.8712.4944.0655.7855.4325.0126.64210.22246.56213.82312.4582.1016.5413.7540.5260.0010.0010.1830.1760.1630.3220.220.2720.1920.1340
Overige kosten -0.84902.2720-0.25-1.7720000-013,809.417-0.355-21.3663.929-3.585-0.3440.1190.7130.1830.1760.163000000
Bedrijfskosten 7.0495.9974.4055.8087.9389.4359.8889.1419.615.70552.97520.09917.1174.2395.6375.149-0.1050.0020.0020.1830.1760.1630.3220.220.2720.1920.1340
Bedrijfsresultaat -7.05-5.998-4.406-5.808-8.188-9.435-9.888-9.141-9.6-15.705-52.976-20.099-17.117-25.605-45.123-5.1490.105-0.001-0.002-0.183-0.176-0.163-0.322-0.22-0.272-0.192-0.1340
Bedrijfsresultaat ratio 00-550.750000000000000000000000000
Totaal overige inkomsten en kosten netto -0.847-0.530.074-0.333-0.924-1.604-0.3530.0582.6182.25722.184-0.6691.114-21.245-39.4864.981-0.261-0-00.2580.3920.3830.3190.2830.2740.2120.0290
Inkomen voor belasting -7.897-6.528-4.332-6.062-8.717-11.039-10.241-9.083-6.982-13.448-30.793-20.773-16.008-25.489-45.128-5.1620.102-0.002-0.0020.0750.2170.22-0.0030.0630.0020.02-0.1050
Inkomen voor belasting ratio 00-541.50000000000000000000000000
Belastingkosten 0-0.042-1.3940.04-0.251.604-4.52-0.058-2.618-2.257-5.350.005255.822-21.361-0.005-0.043-0.0070.073-0.0040.0160.0410.032-0.0320.0350.0090.00400
Nettowinst -7.897-6.528-4.332-6.062-8.717-12.643-5.721-9.025-4.364-11.191-30.793-20.773-16.008-25.489-45.128-5.1620.102-0.002-0.0020.0590.1760.1880.0290.028-0.0070.015-0.1050
Nettowinstmarge 00-541.50000000000000000000000000
WPA (Winst Per Aandeel) -0.75-0.74-0.052-0.074-0.12-0.19-0.086-0.14-0.066-0.18-0.6-0.38-0.38-0.71-16.73-0.140.003-0.15-0.160.0210.0630.0690.0110.011-0.0030.006-0.0560
Verwaterde WPA -0.75-0.74-0.052-0.074-0.12-0.19-0.086-0.14-0.066-0.18-0.6-0.38-0.38-0.71-16.73-0.140.003-0.15-0.160.0210.0630.0690.0110.011-0.0030.006-0.0560
EBITDA -7.049-5.997-4.405-5.687-8.042-11.05-10.262-9.045-9.576-15.704-52.975-20.099-17.116-25.605-45.122-5.1480.105-0.001-0.0020.0750.2170.22-0.0030.0630.0020.02-0.1050
EBITDA ratio 00-550.6250000000000000000000000000